(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 10g

(2S,4R)-4-(4-Bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 2g

1-(3,5-Dichloropyridin-4-yl)ethan-1-one, 98+%, 5g

1-(butan-2-yl)-4-nitro-1H-pyrazole, 95.0%, 2g

1-(Difluoromethyl)-2-methoxybenzene, 98%, 1g

2,6-Dibromo-4-trifluoromethylphenol, 90.0%, 5g

4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile, 95.0%, 100mg

3-Azetidinol, 3-[3-(trifluoromethyl)phenyl]-, hydrochloride (1:1), 98%, 500mg

3-((2-Bromophenyl)amino)cyclohex-2-enone, 95%, 1g

4-Bromo-2-iodo-6-methylaniline, 95%, 100mg

(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 10g

2-(4-tert-Butylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

3-(4-CHLOROPHENYL)PYRROLIDINE HYDROCHLORIDE, 95.0%, 1g